Eagle Chemical

Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products primarily in the areas of oncology, critical care, and orphan diseases. The company utilizes its proprietary drug development platform to enhance the formulation and delivery of existing medicines, aiming to improve patient outcomes and provide more efficient treatment options. Its commercial portfolio includes products such as Bendeka, Belrapzo, and Ryanodex, while its pipeline features several late-stage candidates targeting indications like exertional heat stroke and various cancers. Eagle Pharmaceuticals is known for its expertise in complex formulation and its ability to navigate the 505(b)(2) regulatory pathway to bring improved therapies to market rapidly.